Showing results (91-100 of 120) with videos related to

Sort By:
Pageof 12
Eclinicalmedicine|January 1, 2021
The evaluation of ENGBD versus PTGBD in high-risk acute cholecystitis: A single-center prospective randomized controlled trialPeilei Mu, Yanyan Lin, Xianzhuo Zhang, et al.
BMC Medicine|December 3, 2021
Regular use of proton-pump inhibitors and risk of stroke: a population-based cohort study and meta-analysis of randomized-controlled trialsMan Yang, Qiangsheng He, Fang Gao, et al.
Medcomm|March 14, 2022
SARS-CoV-2 triggered oxidative stress and abnormal energy metabolism in gut microbiotaTuoyu Zhou, Jingyuan Wu, Yufei Zeng, et al.
World Journal of Emergency Surgery : WJES|March 29, 2023
Effectiveness of intraoperative peritoneal lavage with saline in patient with intra-abdominal infections: a systematic review and meta-analysisQi Zhou, Wenbo Meng, Yanhan Ren, et al.
International Journal of Cancer|May 21, 2021
Association of body composition with risk of overall and site-specific cancers: A population-based prospective cohort studyQiangsheng He, Bin Xia, Anran Liu, et al.
Endoscopy International Open|January 22, 2026
Identifying high-risk patients having ERCP as a day surgery with an online prediction platform: Multicohort validation of a machine learning modelBoru Jin, Yi Wang, Xu Zhang, et al.
Molecular & Cellular Proteomics : MCP|October 8, 2025
Comparative N-Glycoproteomics Reveals Subtype-Specific N-Glycosylation Signatures and Immune Associations in CholangiocarcinomaZhili Xia, Li Gao, Meng Hu, et al.
Pharmacological Research|August 1, 2024
Design of the distribution of iron oxide (Fe3O4) nano-particle drug in realistic cholangiocarcinoma model and the simulation of temperature increase during magnetic induction hyperthermiaYawen Lu, Chongfei Huang, WenKang Fu, et al.
BMC Cancer|January 4, 2024
Regular use of paracetamol and risk of liver cancer: a prospective cohort studyLiang Tian, Ningning Mi, Leiqing Wang, et al.
Scientific Reports|November 29, 2024
Biological and genetic characterization of a newly established human primary multidrug-resistant distal cholangiocarcinoma cell line, CBC3T-6Mingzhen Bai, Ruoshui Wang, Chongfei Huang, et al.
Pageof 12